2023-07-10 07:00:29 ET
-
NanoString Technologies ( NASDAQ: NSTG ) on Monday announced preliminary Q2 consolidated revenues of over $44 million, a 37% increase over the same period last year and above the upper end of the guidance range of $40.70 million to $42.5 million.
-
The stock rose about 8% in early trading.
-
NanoString Technologies ( NSTG ) said it expects Spatial biology revenue to be over $23 million, in line with the consensus revenue estimate of $23 million.
-
nCounter revenue, inclusive of all service and other revenue, is expected to be approximately $21 million, above the upper end of our guidance range of $17 to $18 million.
-
The company reiterated its full-year revenue guidance of $175 million–$185 million, representing annual revenue growth of 41% vs. the consensus of $179.19 million.
-
The company is all set to release its Q2 financial results on August 3, 2023.
For further details see:
NanoString Technologies expects Q2 revenue above estimates; reaffirms FY23 guidance